Search Results

Site Search

Drug class testing - Insights

Check out Mayo Clinic Laboratories’ full menu of testing for individual drug classes, including benzodiazepines, stimulants, opioids, alcohol, and more.

Testing Archives - Page 23 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 5 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 6 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 7 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Accurately characterize marijuana use through urine THC testing - Insights

Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ new marijuana monitoring evaluation, which identifies metabolites of both delta-9 tetrahydrocannabinol (THC) and delta-8 THC to accurately identify and...

CPT codes and LOINC update: January 2023 - Insights

This page includes updates posted to the site during the month of January.

Liquid biopsy offers noninvasive DNA testing for cancer care - Insights

Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D., describe Mayo Clinic Laboratories’ liquid biopsy, which analyzes blood samples for genetic information to guide cancer treatment. The circulating tumor DNA assay uses next generation...

Neuromuscular gene panel provides comprehensive analysis: Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D. - Insights

Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D., explain how Mayo Clinic Laboratories' updated neuromuscular gene panel informs diagnosis and treatment. The phenotype-based panel covers the complete list of neuromuscular genes and...

Newborn screening - Insights

Learn more Mayo Clinic Laboratories robust menu of newborn screening testing, which includes both primary and second-tier biochemical and molecular evaluations.